2024 Annual Meeting | H31 - Leveraging Quality Improvement to Increase Efficiency in Neurology Practice (Practice and Policy Hub)

Date Saturday 04/13/24

Time 04:00 PM - 05:00 PM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Hubs (Practice and Policy)

Director(s) Charles Kassardjian, MD, F�鶹��ýӳ��, Jennifer Simpson, MD, Houman Khosravani, MD, PhD, Sara B. Mitchell, MD, Jacob Pellinen, MD

Topic(s) Practice, Policy, and Ethics

Learning Objectives Participants should be able to recognize different quality improvement methodologies and describe change management techniques that can be implemented to improve efficiency in outpatient or inpatient practice, and apply quality improvement methodologies and change management techniques to problems at their health care organizations with insights gained from examples provided.

CME Available 1.00 CME credit

Core Competencies Professionalism, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Introductory

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Event Timeline
04:00 PM - 05:00 PM MDT	Speaker	Leveraging Quality Improvement to Increase Efficiency in Neurology Practice Charles Kassardjian, MD, F�鶹��ýӳ��, Jennifer Simpson, MD, Houman Khosravani, MD, PhD, Sara B. Mitchell, MD, Jacob Pellinen, MD

Faculty Disclosures
Charles Kassardjian, MD, F�鶹��ýӳ��	Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme.
Jennifer Simpson, MD	Dr. Simpson has nothing to disclose.
Houman Khosravani, MD, PhD	Dr. Khosravani has nothing to disclose.
Sara B. Mitchell, MD	Dr. Mitchell has nothing to disclose.
Jacob Pellinen, MD	The institution of Dr. Pellinen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Science. The institution of Dr. Pellinen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals.